trending Market Intelligence /marketintelligence/en/news-insights/trending/8Zz4lqHFKfCosNa0NhQ3rw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Abiomed fiscal Q1 profit falls YOY

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Abiomed fiscal Q1 profit falls YOY

Abiomed Inc. said its GAAP net income for the fiscal first quarter ended June 30 amounted to $1.93 per share, a decrease from $1.95 per share in the year-earlier period.

GAAP net income totaled $88.9 million, a decline from $90.1 million in the prior-year period.

The Danvers, Mass.-based medical-device maker's revenue climbed 15.4% on an annual basis to $207.7 million from $180.0 million.

Abiomed expects total revenue for the fiscal year 2020 to be in the range of $885 million to $925 million, an increase of 15% to 20% over the prior year.